By Nigam Arora & Dr. Natasha Arora
Editor’s Note:
Many of The Arora Report members who subscribe to the corporate bundle and have focused on ZYX Short are up over 20% for the year at a time when Nasdaq 100 is down about 32% – an outperformance by 52%. This is huge!
Here is an example in real time showing how paid members of The Arora Report are making great profits in this bear market.
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.
There are very nice profits on the short position in uranium miner Cameco Corp (CCJ). CCJ is short from an average price of $30.58. It is trading at $22.40 as of this writing. Here are the key points:
- CCJ is partnering with Brookfield Renewable Partners (BEP) to acquire Westinghouse Electric for $7.875B.
- To finance the deal, CCJ announced a $650M bought deal offering of common shares. The deal was done at $21.95 per share.
- CCJ has committed about $2.2B in equity for the deal.
- Westinghouse provides services to about half of the nuclear power plants in the world.
- The deal shows a renewed interest in nuclear power.
Consider taking partial profits in the zone of 🔒 (To see the locked content, please take a 30 day free trial). The new target zone for the remaining position is 🔒.
The new mental stop zone on the remaining position is 🔒.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
